Alto Neuroscience, Inc. (ANRO)

Alto Neuroscience, Inc. (ANRO) is a healthcare company (biotechnology) based in the United States. The share price is $25.71, down 5.20% on the day, which values the company at $1.03B. Price as of 17 Nov 2026, 17:28 UTC, from Yahoo Finance.

Key facts

Share price
$25.71−5.20% today
Market value
$1.03B
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Alto Neuroscience, Inc. in more detail

ANRO trades at -8.7× next year's expected earnings.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Thin interest cover.

1 of the superinvestors tracked here hold ANRO, including Takis Sparaggis (0.0% of the portfolio).

Superinvestors holding ANRO

1 of the investors tracked here report a position in their latest 13F filing.

Alto Neuroscience, Inc. (ANRO): questions and answers

What is Alto Neuroscience, Inc.'s market cap?

Alto Neuroscience, Inc. is valued at $1.03B at a share price of $25.71.

Does ANRO pay a dividend?

Alto Neuroscience, Inc. does not currently pay a regular dividend.

Which famous investors own ANRO?

In their latest quarterly filings, Takis Sparaggis (0.0% of the portfolio) hold ANRO. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Alto Neuroscience, Inc. (ANRO) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ANRO

Underlying data: Yahoo Finance; company filings with the SEC.